In this study, NRGs AIFM1, CCT8, HNRNPA1, KHDRBS1, and SERBP1 were suggested to be the key targets for IDD risk and drug therapy. The gene discussed is HNRNPA1; the disease is intervertebral disk degenerative disorder.